Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 47335-049

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 47335-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl 20 mg Carton

Label for Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL), an injectable liposomal formulation for intravenous use. The label includes product warnings, storage instructions (store refrigerated at 2°C to 8°C, do not freeze), dosage form details, and manufacturer information: Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Ltd., India. The label emphasizes that the product is a cytotoxic agent and must be diluted prior to administration.*

FDA Label Image

Spl 20 mg Vial

Label for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) injectable liposomal dosage form. Distributed by Sun Pharmaceutical Industries, Inc., manufactured by Sun Pharmaceutical Ind. Ltd. Instructions include use of 5% Dextrose Injection for dilution and storage between 2°C to 8°C. The label highlights that it is a cytotoxic agent, must be diluted, and is for intravenous infusion only after dilution.*

FDA Label Image

Spl 50 mg Carton

Packaging label for Doxorubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) sterile injectable solution. The label highlights it as a cytotoxic agent and states it must be diluted prior to administration. It includes storage instructions to refrigerate at 2°C to 8°C and warnings not to substitute this liposomal formulation. The labeler is Sun Pharmaceutical Industries, Inc., with manufacturing in Gujarat, India.*

FDA Label Image

Spl 50 mg Vial

Label for Doxorubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) in a 25 mL single-dose vial. This cytotoxic agent is for intravenous infusion only after dilution. The label states it must be diluted with 5% Dextrose Injection, USP, and instructs storage in refrigerator at 2°C to 8°C without freezing. Distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Ind. Ltd., India.*

FDA Label Image

Spl-doxorubicin-figure (Spl Doxorubicin Figure)

Illustration depicting the structure of a pegylated liposome, showing the MPEG-DSPE coating on the surface, an aqueous core containing entrapped doxorubicin hydrochloride (HCl), and the liposomal bilayer forming the vesicle wall.*

FDA Label Image

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)

Kaplan-Meier curve showing percent of subjects progression-free over time (months), comparing Doxorubicin plus Bortezomib versus Bortezomib alone. The graph includes censored data points and reports a p-value < 0.0001 with hazard ratio 0.55 (95% CI 0.43, 0.71). A table below lists the number of subjects at risk at various time points for both treatment groups.*

FDA Label Image

Spl-doxorubicin-structure (Spl Doxorubicin Structure)

Chemical structure diagram of Doxorubicin Hydrochloride, showing its molecular framework with functional groups, hydroxyls, and hydrochloride component, consistent with the active ingredient in the injectable liposomal formulation.*

FDA Label Image

Spl-doxorubicin-structure1 (Spl Doxorubicin Structure1)

Chemical structure of MPEG-DSPE, showing the molecular formula with polyethoxy groups, amide linkage, phosphate group, and long hydrocarbon chains.*

FDA Label Image

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)

Chemical structure of hydrogenated soy phosphatidylcholine (HSPC) with variable chain lengths m and n, shown as 14 or 16. The diagram illustrates the molecular formula with phosphate, choline, and fatty acid chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.